arrow-positive FNA - Paragon 28, Inc. 8.8 -0.17 (-1.90%)

As of April 26, 2024 4:00 pm EDT
Add to Watchlist
Get new quote

Quote Detail

Last 8.80
Change -0.17
Change % -1.90
Bid 8.25 X 100
Ask 10.18 X 100
Volume 554.08 K
Shares 82.84 M
Market Cap 743.05 M
   
Open 8.95
High 9.18
Low 8.73
Prev Close 8.97
52 Wk High 19.72
52 Wk Low 7.95
EPS -0.5816
P/E n.a.
Div Yield n.a.

Market Headlines

Appointment of Stephen M. Deitsch as new Chief Financial Officer 04/04/2024 11:43AM

(GLOBE NEWSWIRE via COMTEX News Network) -- OXFORD, United Kingdom, April 04, 2024 (GLOBE NEWSWIRE) -- OrganOx, a medical device company which is changing the paradigm in liver transplantation in...

Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024 04/04/2024 08:01AM

ENGLEWOOD, Colo., April 4, 2024 (BUSINESS WIRE) -- Paragon 28, Inc. (NYSE: FNA), ("Paragon 28" or "the Company"), a leading medical device company exclusively focused on the foot and ankle...

Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler(R) R3INFORCE(TM) Extraosseous Repair System 03/28/2024 04:05PM

ENGLEWOOD, Colo., March 28, 2024 (BUSINESS WIRE) -- Paragon 28, Inc. (NYSE: FNA), is pleased to announce the launch of the Grappler(R) R3INFORCE(TM) Extraosseous Repair System designed to restore...

Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue Guidance 02/29/2024 04:05PM

ENGLEWOOD, Colo., February 29, 2024 (BUSINESS WIRE) -- Paragon 28, Inc. (NYSE: FNA) ("Paragon 28" or "Company"), a leading medical device company exclusively focused on the foot and ankle...